Section 13-4007 – Report
On or before December 1, 2020, and each December 1 thereafter, the Department shall report, in accordance with § 2–1257 of the State Government Article, to the Senate Finance Committee and the House Health and Government Operations Committee on: (1) The number of individuals who have been screened through the Program; (2) The types of tests used […]
Section 13-3401 – Definitions
(a) In this subtitle the following words have the meanings indicated. (b) “Family planning providers” means providers of services: (1) Funded under Title X of the federal Public Health Service Act as of December 31, 2016; and (2) That lost eligibility for Title X funding as a result of the termination of federal funding for providers because of: (i) The […]
Section 13-3801 – Definitions [Subtitle Subject to Abrogation]
// EFFECTIVE UNTIL JUNE 30, 2025 PER CHAPTER 708 OF 2018 // (a) In this subtitle the following words have the meanings indicated. (b) “Advisory Board” means the Advisory Board for the Task Force established under § 13–3806(a) of this subtitle. (c) “Health inequities” means the unfair and avoidable differences in health status seen within and between countries. […]
Section 13-3402 – General Consideration
(a) There is a Family Planning Program in the Department. (b) The purpose of the Program is to ensure the continuity of family planning services in the State. (c) The Program shall provide family planning services to individuals who are eligible for family planning services through family planning providers that meet Program requirements. (d) The Department may adopt regulations […]
Section 13-3802 – Task Force Established [Subtitle Subject to Abrogation]
// EFFECTIVE UNTIL JUNE 30, 2025 PER CHAPTER 708 OF 2018 // There is a Task Force on the Social Determinants of Health in Baltimore City.
Section 13-3501 – Definitions
(a) In this subtitle the following words have the meanings indicated. (b) “Co–prescribing” means, with respect to an opioid overdose reversal drug, the practice of prescribing the drug in conjunction with an opioid prescription for a patient at an elevated risk of overdose. (c) “Opioid overdose reversal drug” means naloxone or a similarly acting and equally safe drug […]
Section 13-3803 – Purpose and Duties [Subtitle Subject to Abrogation]
// EFFECTIVE UNTIL JUNE 30, 2025 PER CHAPTER 708 OF 2018 // (a) The purpose of the Task Force is to function as a multisector collaborative action group to address the social determinants of health in Baltimore City. (b) The Task Force shall: (1) Identify and examine the negative social factors that: (i) Are causing hardship for residents of […]
Section 13-3502 – Establishment of Guidelines for Co-Providing Opioid Overdose Reversal Drugs
(a) The Secretary shall establish guidelines for the co–prescribing of opioid overdose reversal drugs that are applicable to all licensed health care providers in the State who are authorized by law to prescribe a monitored prescription drug, as defined in § 21–2A–01 of this article. (b) The guidelines established under subsection (a) of this section shall address […]
Section 13-3804 – Membership [Subtitle Subject to Abrogation]
// EFFECTIVE UNTIL JUNE 30, 2025 PER CHAPTER 708 OF 2018 // (a) (1) The Task Force consists of the following members appointed by the Advisory Board: (i) Representatives of community organizations, academic institutions, law enforcement, and State and local government; (ii) Health care providers; (iii) Urban planners; (iv) Entrepreneurs; (v) Members of the Black Mental Health Alliance; and (vi) Other individuals with […]
Section 13-3601 – Definitions
(a) In this subtitle the following words have the meanings indicated. (b) “Emergency medical services provider” has the meaning stated in § 13–516 of the Education Article. (c) “Law enforcement officer” has the meaning stated in § 3–101 of the Public Safety Article. (d) “Overdose” means a condition, including extreme physical illness, decreased level of consciousness, respiratory depression, coma, […]